ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 

ANZMTG 01.17 STOP GAP Trial - Canadian Collaborative Group Protocol: STOP-GAP - A randomised phase III study of duration of anti-PD1 therapy in metastatic melanoma; this proposal is for a parallel sister protocol running in ANZ

Study status - In Development
ANZ Clinical Trials Registry # - In Progress
ClinicalTrials.gov identifier - In Progress
 

Principal Investigator's details:
A/Prof Mark Shackleton
A/Prof Victoria Atkinson

Email: 

ANZMTG coordinator details:

Email: anzmtg@melanoma.org.au
 
Documents (PDF downloads):
  • Trial Synopsis
  • Trial Protocol
  • Case Report Forms
  • Case Report Forms Completion Guidelines
  • Operations Manual
  • Trial Publications and Presentations
  • Site Contacts


Return to Previous Page